Professor Kehn-Hall to Discuss Research on Viral Infections

Posted: April 23, 2013 at 5:00 am, Last Updated: April 24, 2013 at 7:03 am

Print Friendly

By Frances Womble

Kylene Kehn-Hall. Creative Services photo

Kylene Kehn-Hall. Creative Services photo

Kylene Kehn-Hall, assistant professor in the National Center for Biodefense and Infectious Diseases, will give this semester’s final lecture in the Vision Series on Monday, April 29, at 7:30 p.m. in the Hylton Performing Arts Center on the Prince William Campus.

Tickets are not required, and an informal reception with light refreshments will follow the lecture, “Identifying Altered Host Pathways in Emerging Viral Infections: Implications for Therapeutics and Diagnostics.”

In the lecture, Kehn-Hall will explain how Rift Valley Fever Virus and Venezuelan Equine Encephalitis Virus are infectious pathogens and even biological threat agents. Both viruses are transmitted by mosquitoes and pose a risk to humans and livestock, and neither infection is treatable at this time. Her lecture will focus on host pathways that are altered during these infections, with the goal of utilizing this information for therapeutic and diagnostic applications.

Kehn-Hall’s research focuses on the development of therapeutics for emerging infectious diseases, specifically Bunyaviruses, Alphaviruses and HIV. Previously, she conducted research at the FBI Counterterrorism and Forensic Science Research Lab, focusing on application-based science and assay (analysis procedure) development, and at the United States Army Medical Research Institute of Infectious Disease, focusing on assay development and the development and identification of novel therapeutics for hemorrhagic fever viruses.

She has a PhD in biochemistry and molecular biology from The George Washington University, where she studied retroviral pathogenesis and breast cancer biology.

Write to Robin Herron at rherron@gmu.edu

Leave a Comment